TRESK Antibodies

Santa Cruz Biotechnology features a diverse variety of TRESK Antibodies for advanced research in ion channel biology. TRESK Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRESK, or KCNK18, is a member of the two-pore domain potassium channel family and plays a crucial role in regulating neuronal excitability and pain perception. TRESK functions are essential for maintaining cellular homeostasis and modulating various physiological processes. Research has shown that TRESK dysfunction contributes to several pain disorders, making it a significant target for therapeutic intervention. Understanding TRESK's molecular mechanisms and signaling pathways can lead to breakthrough treatments for neurological conditions. Investigating TRESK expression patterns helps reveal its distribution across different tissue types and cellular compartments. Exploring TRESK's role in pain modulation provides insights into developing targeted pain management strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of ion channel biology and developing innovative therapeutic approaches.